Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11701
PUT
Allogene Therapeutics
ALLO
$722M
| $75.5K | ﹤0.01% |
51,700
+13,800
| +36% | +$26K |
|
11702
TRX Gold Corp
TRX
$400M
| $75.5K | ﹤0.01% |
242,667
-288,729
| -54% | -$91.1K |
|
11703
CALL
Quest Resource Holding
QRHC
$30.4M
| $75.4K | ﹤0.01% |
+29,000
| New | +$137K |
|
11704
SEALSQ Corp
LAES
$581M
| $75.4K | ﹤0.01% |
+28,997
| New | +$108K |
|
|
FT
11705
Franklin Universal Trust
FT
$195M
| $75.4K | ﹤0.01% |
10,012
-5,220
| -34% | -$39.2K |
|
11706
PUT
RLX Technology
RLX
$2.2B
| $75.4K | ﹤0.01% |
40,100
-11,800
| -23% | -$26.2K |
|
|
LNAI
11707
Lunai Bioworks
LNAI
$10.7M
| $75.4K | ﹤0.01% |
1,735
+963
| +125% | +$61.6K |
|
11708
OptimumBank Holdings
OPHC
$110M
| $75.2K | ﹤0.01% |
+18,287
| New | +$82K |
|
|
FORA
11709
DELISTED
Forian
FORA
| $75.1K | ﹤0.01% |
+37,559
| New | +$83.7K |
|
|
GLO
11710
Clough Global Opportunities Fund
GLO
$246M
| $75K | ﹤0.01% |
15,336
-40,124
| -72% | -$207K |
|
11711
PUT
Xeris Biopharma Holdings
XERS
$1.57B
| $74.7K | ﹤0.01% |
+13,600
| New | +$54.9K |
|
|
SRTA
11712
PUT
Strata Critical Medical Inc
SRTA
$546M
| $74.5K | ﹤0.01% |
27,300
+11,700
| +75% | +$42K |
|
|
BHR
11713
CALL
Braemar Hotels & Resorts
BHR
$142M
| $74.5K | ﹤0.01% |
29,900
-50,700
| -63% | -$138K |
|
11714
CALL
Sasol
SSL
$7.44B
| $74.4K | ﹤0.01% |
17,600
-200
| -1% | -$907 |
|
11715
CBAK Energy Technology Ltd
CBAT
$76.5M
| $74.3K | ﹤0.01% |
93,249
+83,182
| +826% | +$73.7K |
|
|
ORGN
11716
PUT
DELISTED
Origin Materials
ORGN
| $74.3K | ﹤0.01% |
3,750
+410
| +12% | +$11.3K |
|
11717
Cibus
CBUS
$128M
| $74.1K | ﹤0.01% |
39,611
+11,650
| +42% | +$27.3K |
|
11718
CALL
Gran Tierra Energy
GTE
$358M
| $74K | ﹤0.01% |
15,000
-13,300
| -47% | -$76.3K |
|
|
BZAI
11719
CALL
Blaize Holdings
BZAI
$74.1M
| $73.5K | ﹤0.01% |
+36,400
| New | +$165K |
|
11720
CALL
3D Systems Corp
DDD
$570M
| $73.4K | ﹤0.01% |
34,600
-197,300
| -85% | -$671K |
|
11721
PUT
PetMed Express
PETS
$40.1M
| $73.3K | ﹤0.01% |
17,500
-11,500
| -40% | -$52.2K |
|
|
KYNB
11722
CALL
Kyntra Bio
KYNB
$32.4M
| $73.2K | ﹤0.01% |
9,440
+2,944
| +45% | +$35.3K |
|
|
ARTV
11723
Artiva Biotherapeutics
ARTV
$584M
| $73.1K | ﹤0.01% |
+24,357
| New | +$131K |
|
11724
Worksport
WKSP
$9.64M
| $72.8K | ﹤0.01% |
22,809
+10,567
| +86% | +$77.1K |
|
11725
Reborn Coffee
REBN
$11M
| $72.7K | ﹤0.01% |
+19,713
| New | +$70.8K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.